You are here

  • Home
  • Archive
  • Volume 28, Issue e1
  • Cost-minimisation analysis of rectal cancer neoadjuvant chemoradiotherapy based on fluoropyrimidines (capecitabine versus 5-fluorouracil)

Article metrics

Article menu
Download PDFPDF
Original research
Cost-minimisation analysis of rectal cancer neoadjuvant chemoradiotherapy based on fluoropyrimidines (capecitabine versus 5-fluorouracil)

 

Online download statistics by month:

Online download statistics by month: March 2020 to March 2024

AbstractFullPdf
Mar 202023928
Apr 202067634
May 202021310
Jun 20205500
Jul 20204600
Aug 20204301
Sep 20203800
Oct 202017600
Nov 20209801
Dec 20202200
Jan 20215700
Feb 20214611
Mar 202119000
Apr 20214300
May 20213211
Jul 2021100
Aug 2021200
Sep 2021300
Oct 20218922
Nov 20211510
Dec 202119522
Jan 202214730
Feb 202226321
Mar 202213122
Apr 202212712
May 20229700
Jun 202210331
Jul 20229952
Aug 20227021
Sep 202211742
Oct 202211920
Nov 20228440
Dec 20223410
Jan 202312701
Feb 20237800
Mar 20236000
Apr 20232500
May 20234804
Jun 202313100
Jul 20233800
Aug 20235200
Sep 20231801
Oct 20233400
Nov 20233232
Dec 20233301
Jan 20243200
Feb 20242500
Mar 20244551
Total44485041